BiotechTube
Seonix Bio

Seonix Bio

San Diego, United States· Est.
seonixbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Seonix Bio is an early-stage diagnostics company commercializing a polygenic risk score (PRS) test called SightScore™ for predicting genetic risk of glaucoma and age-related macular degeneration (AMD). The company leverages extensive genetic research published in leading journals to provide a clinically relevant tool intended to guide monitoring and management decisions in ophthalmology. Currently available in the US, Australia, and New Zealand as a laboratory-developed test (LDT), Seonix targets both clinical use and research collaborations while navigating the pre-FDA approval regulatory pathway.

Ophthalmology

Technology Platform

Polygenic Risk Score (PRS) algorithm for glaucoma and age-related macular degeneration (AMD), calculated from saliva-based DNA genotyping.

Opportunities

The high heritability and prevalence of glaucoma and AMD create a large addressable market for genetic risk stratification.
The shift towards personalized, preventive eye care and the potential for SightScore to be used as a biomarker for patient selection in clinical trials present significant growth avenues.

Risk Factors

Key risks include challenges in obtaining insurance reimbursement and demonstrating clear clinical utility to drive physician adoption.
The company also faces regulatory uncertainty as a CLIA-lab service and potential competition from larger genomic firms entering the polygenic risk score space.

Competitive Landscape

Seonix operates in the emerging niche of ophthalmic polygenic risk scores. It faces potential competition from large direct-to-consumer genetics companies (e.g., 23andMe) that may offer similar risk reports, specialized diagnostic labs, and academic medical centers developing their own scores. Its focus on deep ophthalmology-specific validation and clinical service is a differentiating factor.

More companies in Diagnostics & Precision Medicine →More companies in United States →